Stock DZ
18.01.2018 kl 21:41

Good evening.

There is something about the top 10 BP collaboration that puzzles me, I hope to find some answers here :)

We should all agree that BioNTech and the top 10 BP are both nucleic acid therapeutics leaders, in otherwords: COMPETITORS.

Now we have a BioNTech board member (Professor Christoph Huber) who serves in the Scientific Advisory Committee at PCI Biotech, which means BioNTech should have some knowledge on who the top 10 BP is and what is up to.

is it just me who sees a "conflict of interest" here ??